NEW YORK, Nov. 23 (GenomeWeb News) - The Blueprint Initiative, a non-profit research program based at the Samuel Lunenfeld Research Institute at Toronto's Mt. Sinai Hospital, has "fully expended available core funding in both Canada and Singapore," according to a notice on its website, and will stop curating the Biomolecular Interaction Network Database (BIND).

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.